Transcranial Magnetic Stimulation (TMS) technology received FDA-approval in 2008 to treat depression patients whose symptoms are non-responsive to antidepressant medications. Historically, depression has been difficult to treat in about half of all diagnosed patients, marking TMS treatment as an extremely important development for the field of psychiatry. Let us imagine a new patient...